Effects of a Stretching Protocol in Patients With Hip Osteoarthritis

NCT ID: NCT03702595

Last Updated: 2020-01-21

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 15 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-08-01
• Study Completion Date: 2018-12-30

Brief Summary

Hip osteoarthritis (OA) is one of the most prevalent chronic disease in the world. Clinical guidelines recommend non-pharmacological conservative treatments for the management of OA. Hip flexors seems to play an important role in the development of hip OA but there is no published studies evaluating the results of a stretching protocol of hip flexors in hip OA patients.

The objective of this trial is to evaluate if a stretching protocol of hip flexors is more effective in symptoms, functional capacity , range of motion, strength, muscular length, pain threshold and anxiety and depression compared to control.

For this purpose the investigators conduct a single-group, pretest-posttest clinical trial.The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

The variables are measured at the beginning and at the end of treatment of the control phase, and at the end of the stretching protocol phase.

Conditions

Hip Osteoarthritis

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Interventional group

Hip flexors stretching protocol

Group Type: EXPERIMENTAL

Hip flexors stretching protocol

Intervention Type: OTHER

Stretching protocol of rectus femoris, vastus lateralis and iliopsoas according to Kaltenborn- Evjenth Orthopaedic Manual Therapy Concept (OMT)

Interventions

Hip flexors stretching protocol

Stretching protocol of rectus femoris, vastus lateralis and iliopsoas according to Kaltenborn- Evjenth Orthopaedic Manual Therapy Concept (OMT)

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Diagnosed medically with a X-Ray test
• American College of Rheumatology Criteria

Exclusion Criteria

• Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
• Vascular or neurological disease.
• Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
• Grade IV in Kellgren and Laurence Scale

• Minimum Eligible Age: 50 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Valladolid

OTHER

Sponsor Role: collaborator

Universidad de Zaragoza

OTHER

Sponsor Role: lead

Responsible Party

Luis Ceballos Laita

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Sandra Jiménez del Barrio

Soria, , Spain

Luis Ceballos Laita

Zaragoza, , Spain

Countries

Spain

Other Identifiers

1955

Identifier Type: -

Identifier Source: org_study_id